Han M, Napier C, Frölich S, Teber E, Wong T, Noble J, et al. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency. J Cell Sci. 2019;132: pubmed publisher

Crow M, Cristea I. Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation. Mol Cell Proteomics. 2017;16:S200-S214 pubmed publisher

Zhang W, Ge K, Zhao Q, Zhuang X, Deng Z, Liu L, et al. A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4. Oncotarget. 2015;6:20345-55 pubmed

Jamin A, Thunuguntla P, Wicklund A, Jones C, Wiebe M. Barrier to auto integration factor becomes dephosphorylated during HSV-1 Infection and Can Act as a host defense by impairing viral DNA replication and gene expression. PLoS ONE. 2014;9:e100511 pubmed publisher

Cook K, Tsopurashvili E, Needham J, Thompson S, Cristea I. Restructured membrane contacts rewire organelles for human cytomegalovirus infection. Nat Commun. 2022;13:4720 pubmed publisher